Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality8/10

Nutex Health reports Q2 profitability surge, cash flow gains, and cost relief

Aug 6, 2026, 6:01 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Strong profit swing, sizable cost savings, and planned hospital openings support near-term upside; balance sheet remains healthy with ample cash and low net debt, increasing potential for multiple expansion.

AI summary

What happened, with direct paths to the underlying reporting

Nutex Health posted a strong Q2 2026, with net income of $65.8 million and EPS of $9.38, supported by EBITDA of $94.1 million and Adjusted EBITDA of $90.0 million. Hospital visits rose 9.6% year over year to 49,962, while HaloMD and CMS IDR changes delivered meaningful contract-cost reductions. The company also projects three new hospitals opening this year, underpinning earnings power as cash balance remains robust at $205.2 million and debt stays modest at $31.1 million.

Q2 2026 net income $65.8m, EPS $9.38; swings from prior loss.
Hospital visits up 9.6% YoY to 49,962; same-hospital visits up 6.3%.
Six-month revenue down 6.3% to $427.2m; IDR tailwinds fading.
HaloMD and CMS IDR changes cut contract services by $52.3m; 25–30% future savings.
Company guiding three new hospitals openings later 2026; strong cash, modest debt.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.